|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.48 CNY | +2.14% |
|
+4.49% | -9.26% |
| 06-02 | Joincare Pharmaceutical Gets China Regulatory Acceptance for Ankylosing Spondylitis Drug Application | MT |
| 06-02 | Joincare Pharmaceutical Extends Employee Stock Ownership Plan | MT |
| Market Cap | 18.7B 2.77B 2.42B 2.24B 2.06B 3.89B 267B 3.96B 26.76B 10.48B 130B 10.39B 10.17B 450B | P/E 2026 * |
13.1x | P/E 2027 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 18.7B 2.77B 2.42B 2.24B 2.06B 3.89B 267B 3.96B 26.76B 10.48B 130B 10.39B 10.17B 450B | EV / Sales 2026 * |
1.16x | EV / Sales 2027 * | 1.1x |
| Free-Float |
47.5% | Yield 2026 * |
2.1% | Yield 2027 * | 2.19% |
| 1 day | +2.14% | ||
| 1 week | +4.49% | ||
| Current month | +11.25% | ||
| 1 month | +6.83% | ||
| 3 months | -5.50% | ||
| 6 months | -12.08% | ||
| Current year | -9.26% |
| 1 week | 9.98 |  | 10.7 |
| 1 month | 9.08 | | 10.7 |
| Current year | 9.08 | | 12.41 |
| 1 year | 9.08 | | 14.21 |
| 3 years | 9.08 | | 14.21 |
| 5 years | 9.08 | | 14.24 |
| 10 years | 6.28 | | 22.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nan Qi Lin
PSD | President | 44 | 2024-08-26 |
Qing Feng Qiu
DFI | Director of Finance/CFO | 55 | 2020-11-22 |
Zhi Wei Xing
PRN | Corporate Officer/Principal | 40 | 2024-04-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Bao Guo Zhu
CHM | Chairman | 64 | 2001-12-31 |
Qing Feng Qiu
CHM | Chairman | 55 | 2005-05-31 |
Guang Xia Liu
BRD | Director/Board Member | 57 | 2001-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/18/25 | Sell | 2,000 | 0.0001% | |||
| 12/26/23 | Buy | Chief Executive Officer | 60,000 | 0.0031% | ||
| 12/19/22 | Buy | Executive/Senior Manager | 180,000 | 0.0093% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.14% | +4.49% | -14.03% | -14.73% | 2.7B | |
| -2.73% | -3.51% | +48.62% | +152.87% | 1,051B | |
| -1.67% | -3.18% | +52.00% | +56.75% | 609B | |
| -0.44% | +2.14% | +33.88% | +84.04% | 450B | |
| -0.75% | -1.46% | +28.32% | +22.33% | 330B | |
| -1.52% | -0.95% | +33.38% | +38.39% | 284B | |
| -1.70% | -3.54% | +20.26% | +17.88% | 263B | |
| -0.58% | +1.78% | -20.89% | -38.37% | 223B | |
| -0.58% | +0.21% | +23.55% | +56.94% | 198B | |
| -0.80% | +2.60% | +23.09% | +68.71% | 167B | |
| Average | +0.11% | +0.70% | +22.82% | +44.48% | 357.78B | |
| Weighted average by Cap. | +0.62% | +0.03% | +35.21% | +75.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.16B 2.39B 2.09B 1.93B 1.78B 3.36B 231B 3.42B 23.12B 9.06B 113B 8.98B 8.78B 389B | 16.97B 2.51B 2.2B 2.03B 1.87B 3.53B 242B 3.59B 24.27B 9.51B 118B 9.43B 9.22B 408B |
| Net income | 1.46B 216M 189M 175M 160M 303M 20.82B 309M 2.09B 818M 10.17B 811M 793M 35.09B | 1.54B 227M 199M 184M 169M 319M 21.92B 325M 2.2B 861M 10.71B 854M 835M 36.94B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | CN¥10.48 | +2.14% | 21,501,316 |
| 26-07-17 | CN¥10.26 | -3.57% | 24,042,911 |
| 26-07-16 | CN¥10.64 | +1.14% | 28,182,131 |
| 26-07-15 | CN¥10.52 | +2.53% | 28,524,383 |
| 26-07-14 | CN¥10.26 | +1.58% | 21,940,364 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600380 Stock
Select your edition
All financial news and data tailored to specific country editions
